<code id='DB12999AAE'></code><style id='DB12999AAE'></style>
    • <acronym id='DB12999AAE'></acronym>
      <center id='DB12999AAE'><center id='DB12999AAE'><tfoot id='DB12999AAE'></tfoot></center><abbr id='DB12999AAE'><dir id='DB12999AAE'><tfoot id='DB12999AAE'></tfoot><noframes id='DB12999AAE'>

    • <optgroup id='DB12999AAE'><strike id='DB12999AAE'><sup id='DB12999AAE'></sup></strike><code id='DB12999AAE'></code></optgroup>
        1. <b id='DB12999AAE'><label id='DB12999AAE'><select id='DB12999AAE'><dt id='DB12999AAE'><span id='DB12999AAE'></span></dt></select></label></b><u id='DB12999AAE'></u>
          <i id='DB12999AAE'><strike id='DB12999AAE'><tt id='DB12999AAE'><pre id='DB12999AAE'></pre></tt></strike></i>

          Home / fashion / knowledge

          knowledge


          knowledge

          author:hotspot    Page View:987
          Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

          In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

          The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks. 

          advertisement

          “Oh, crap,” Secrist said to herself.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In